Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1822]

COVID-19: Treating breast cancer and the knock on effects of the coronavirus...

Prof Stephen Johnston - Royal Marsden NHS Foundation Trust, London, UK

COVID-19: Treating breast cancer and the knock on effects of the coronavirus pandemic ( Prof Stephen Johnston - Royal Marsden NHS Foundation Trust, London, UK )

Pembrolizumab plus chemotherapy for patients with metastatic triple-negative...

Dr Javier Cortés - IOB Institute of Oncology, Madrid and Barcelona, Spain

Pembrolizumab plus chemotherapy for patients with metastatic triple-negative breast cancer ( Dr Javier Cortés - IOB Institute of Oncology, Madrid and Barcelona, Spain )

COM701 as a monotherapy and in combination with nivolumab for various advanced...

Dr. Ecaterina Dumbrava - MD Anderson Cancer Centre, Houston, USA

COM701 as a monotherapy and in combination with nivolumab for various advanced solid tumours ( Dr. Ecaterina Dumbrava - MD Anderson Cancer Centre, Houston, USA )

Diagnosing, treating and managing breast cancer during COVID-19

Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium

Diagnosing, treating and managing breast cancer during COVID-19 ( Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium )

COVID-19: Using oncology drugs and surgery during the coronavirus pandemic

Dr. Paolo Ascierto - Istituto Nazionale Tumori, Milan, Italy

COVID-19: Using oncology drugs and surgery during the coronavirus pandemic ( Dr. Paolo Ascierto - Istituto Nazionale Tumori, Milan, Italy )

TERAVOLT: Thoracic cancers indicate an unexpectedly high mortality rate in...

Dr Heather Wakelee - Stanford University Medical Center, Stanford, USA

TERAVOLT: Thoracic cancers indicate an unexpectedly high mortality rate in patients with COVID-19 ( Dr Heather Wakelee - Stanford University Medical Center, Stanford, USA )

IMPRIME 1: Combination of pembrolizumab and a novel innate immune activator...

Dr Steven O'Day - John Wayne Cancer Institute, Santa Monica, USA

IMPRIME 1: Combination of pembrolizumab and a novel innate immune activator, Imprime PGG, in second-line mTNBC ( Dr Steven O'Day - John Wayne Cancer Institute, Santa Monica, USA )

COVID-19: Management of non-small cell lung cancer patients during the...

Dr Heather Wakelee - Stanford University, Stanford, USA

COVID-19: Management of non-small cell lung cancer patients during the coronavirus pandemic ( Dr Heather Wakelee - Stanford University, Stanford, USA )

Gynaecological cancers in the era of fertility preservation

Dr Fedro Peccatori - European Institute of Oncology, Milan, Italy

Gynaecological cancers in the era of fertility preservation ( Dr Fedro Peccatori - European Institute of Oncology, Milan, Italy )

I-SPY 2: Durvalumab in combination with olaparib and paclitaxel in high-risk...

Prof Lajos Pusztai - Yale Cancer Center, New Haven, USA

I-SPY 2: Durvalumab in combination with olaparib and paclitaxel in high-risk HER2 negative stage II/III breast cancer ( Prof Lajos Pusztai - Yale Cancer Center, New Haven, USA )

An oncologist's experience of managing breast cancer during the COVID-19...

Prof Alessandra Gennari - University Hospital of Novara, Piedmont, Italy

An oncologist's experience of managing breast cancer during the COVID-19 outbreak ( Prof Alessandra Gennari - University Hospital of Novara, Piedmont, Italy )

COVID-19: The situation in Florida and managing lung cancer patients

Dr. Luis Raez - Memorial Healthcare System, Florida, Miami

COVID-19: The situation in Florida and managing lung cancer patients ( Dr. Luis Raez - Memorial Healthcare System, Florida, Miami )

More from ecancer